Postgastrectomy Syndromes: Clinical Trials

3 trials for Postgastrectomy Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Postgastrectomy Syndromes: new trials by email Literature Review of Postgastrectomy Syndromes trials Research Report on Postgastrectomy Syndromes

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
SOM230 - Dumping Syndrome
Phase 2CompletedNovartis Pharmaceuticals432013-01-082017-05-10
Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome
Pasireotide, Placebo - Postoperative Dumping Syndrome
Phase 2CompletedUniversitaire Ziekenhuizen KU Leuven92008-09-012013-07-10
SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
Lanreotide 90 mg slow release formulation, Placebo - Dumping Syndrome
Phase 2CompletedUniversitaire Ziekenhuizen KU Leuven242008-04-012023-01-27

Narrower conditions

Dumping Syndrome (3)  ·  Hypoglycemia (1)

Broader conditions

Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Postoperative Complications (3)  ·  Stomach Diseases (3)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

pasireotide (2)  ·  Delayed-Action Preparations (1)  ·  lanreotide (1)

Sponsors

Universitaire Ziekenhuizen KU Leuven (2)  ·  Novartis Pharmaceuticals (1)

Countries

Belgium (3)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Jan Tack, M.D., Ph.D. (1)

NIH funding

2008 (2)